M. Hylkema (Groningen, The Netherlands), P. Kirkham (London, United Kingdom)
The bronchodilator effects of the novel anti-inflammatory compound TPI 1020, alone and in combination with formoterol, in conscious guinea pigs
D. Turner, E. Kidd, W. Ford, N. Ferrari, K. Broadley (Cardiff, United Kingdom; Montreal, Canada)
|   |
Effect of Mn(III tetrakis (4-benzoic acid) porphyrin on inflammation and fibrosis in amiodarone-induced pneumotoxicity in rats
G. Stavreva, V. Dancheva, A. Stoyanova, L. Terziev, T. Popova, Y. Ivanov (Pleven, Bulgaria)
|  |
Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model
T. Raupach, L. Luethje, H. Koegler, H. C. Duve, G. Hasenfuss, S. Andreas (Goettingen, Kassel, Germany)
| |
Acrolein induces airway remodeling in mice via NF-κB pathway
J. Lin, Y. P. Li, F. Q. Wen, L. Chen, J. An, Y. Hou, X. R. Hu, Q. Liu, T. Wang, S. F. Zhang, D. Xu (Chengdu, China)
| |
Inhibition of c-kit tyrosine kinase by sunitinib alleviates airway remodeling in a mouse model of chronic asthma
M. Huang, L. Xuan, H. He, K. Yin (Nanjing, China)
| |
Bronchoprotective role of PGE2 synthesized via microsomal PGE synthase on airway hyperresponsiveness in vivo
L. Swedin, C. Kemi, S. Georén, S. Lindgren, A. Ryrfeldt, S. E. Dahlén, M. Adner (Stockholm, Södertälje, Sweden)
| |
Anti-asthmatic effects of losartan, a blocker of angiotensin II type 1 receptor, in a rat model of allergic asthma
I. L. Dumitriu, B. Gurzu, E. Cojocaru, P. Plamadeala, I. Ciureanu, S. M. Slatineanu, M. Costuleanu, G. Petrescu (Iasi, Romania)
| |
Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model
J. Mo, A. H. Jansson, E. Morin, A. Smailagic, A. Nelinder, K. Walles, A. M. Dutius Andersson, M. Kvist-Reimer, K. Stenvall, P. Strandberg, H. Vissing, T. Eriksson, J. Hansson (Lund, Sweden)
| |